Western blot of Bcl-w antibody
BCL2L2 / Bcl-w Antibody (100-180 aa, C-terminal)
| Antibody: | Rabbit Polyclonal |
| Applications: | Enzyme-Linked Immunosorbent Assay, Immunofluorescence, Immunohistochemistry (general), Western Blot |
| Reactivity: | Human, Mouse, Rat |
| Format: | Liquid |
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- Bcl-w antibody LS-C382259 is an unconjugated rabbit polyclonal antibody to Bcl-w (BCL2L2) (100-180 aa, C-terminal) from human. It is reactive with human, mouse and rat. Validated for ELISA, IF, IHC and WB. Cited in 2 publications.
- Application
- ELISA, IF, IHC, WB
- Reactivity
- Hu, Ms, Rt
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- BCLW | BCL2-L-2 | BCL2L2 | KIAA0271 | PPP1R51 | Apoptosis regulator Bcl-W | Bcl-2-like protein 2 | BCL-W | BCL2-like 2
- Recommended Dilution: ELISA
- 1:10000
- Recommended Dilution: IF/ICC
- 1:200 - 1:1000
- Recommended Dilution: IHC
- 1:100 - 1:300
- Recommended Dilution: WB
- 1:500 - 1:2000
- UniProt Number
- Q92843
- NCBI GenBank
- NM_004050 | NP_004041.1
- SwissProt
- Q92843
Target
- Target
- Human BCL2L2 / Bcl-w
- Antigen Species
- Human
- Epitope
- Bcl-w Polyclonal Antibody detects endogenous levels of Bcl-w protein.
- Gene Name
- BCL2L2
Antibody
- Host Species
- Rabbit
- Clonality
- Polyclonal
- Isotype
- IgG
Immunogen
- Immunogen
- Synthesized peptide derived from human Bcl-w
- Immunogen Type
- Synthetic Peptide (Linear)
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- PBS, 0.02% Sodium Azide, 50% Glycerol, 0.5% BSA
- Preservative
- Yes
- Purification Method
- Affinity Purified
Storage & Handling
- Storage Conditions
- Store at -20°C. Avoid freeze-thaw cycles.
- Recommended Storage Buffer
- PBS
Bcl-2 Is a Therapeutic Target for Hypodiploid B-Lineage Acute Lymphoblastic Leukemia. Ernesto Diaz-Flores, Evan Q Comeaux, Kailyn L Kim, Ella Melnik, Kyle Beckman, Kara L Davis, Kevin Wu, Jon Akutagawa, Olga Bridges, Roberta Marino, Margo Wohlfeil, Benjamin S Braun, Charles G Mullighan, Mignon L Loh. Cancer research. 2019 May;79:2339-2351.
PubMed: 30862722 · PMC: PMC6497548
CRISPR-Cas9-based mutagenesis frequently provokes on-target mRNA misregulation. Rubina Tuladhar, Yunku Yeu, John Tyler Piazza, Zhen Tan, Jean Rene Clemenceau, Xiaofeng Wu, Quinn Barrett, Jeremiah Herbert, David H Mathews, James Kim, Tae Hyun Hwang, Lawrence Lum. Nature communications. 2019 September;10:4056.
PubMed: 31492834 · PMC: PMC6731291